Related to GVK and Excel PharmaStudies Join Forces to Help Sponsors Conduct Clinical Trials in India and China

• Cosmo Bio to Distribute Bio-Quant’s Discovery and Preclinical CRO Services in Japan
  
• ICON and Tigermed Team Up to Facilitate Access to Chinese Patient Populations
  
• PPD Opens Vaccine Clinical Research Center in Taizhou, China
  
• Abbott Boosts Presence in India with Acquisition of Generics Business for $3.72B
  
• Thermo Fisher Opens New Technology Center in Shanghai
  
• PPD Inks Deal with HIHT University to Increase Network in Northern India
  
• Advinus to Utilize Corning’s Epic Technology for Assay Development and Screening
  
• Qiagen Sets Up Subsidiary in India as Part of Asian Expansion Effort
  
• Quintiles Deepens China Commitment with New CRO
  
• Novasep Opens New Facility in Shanghai to Meet East Asia Demand
  
• Radiant Strikes Deal with Spectrum to Provide CRO Services Across India
  
• Novotech and ETI Ally to Harness Indian Clinical Research Opportunities
  
• PerkinElmer Makes Two Acquisitions to Pad Diagnostics Business in Emerging Markets
  
• Prodrug of Eisai’s Antifungal to Be Investigated in Chagas
  
• PPD Acquires BioDuro to Further Expand Its Outsourcing Capabilities in China
  
• GVK Biosciences Joins ResearchPoint Global’s Worldwide CRO Network
  
• PPD Continues Asia Expansion with Plans for New Facilities in the Philippines and India
  
• Charles River to Take Over Sino-U.S. CRO WuXi in Deal Worth $1.6B
  
• Icon Sets Up Additional Lab Facility in China
  
• PPD to Spin Out Compound-Partnering Segment, Acquire Chinese CRO, and Invest $100M in Celtic Therapeutics